These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5663564)

  • 21. Effect of cholera enterotoxin preparations on cutaneous response in rabbit under varied conditions.
    Singh A; Gaind SK; Sethi SK
    Zentralbl Bakteriol Orig A; 1976 Nov; 236(2-3):288-93. PubMed ID: 13591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enterotoxin production by Vibrio cholerae and Vibrio mimicus grown in continuous culture with microbial cell recycle.
    Spira WM; Fedorka-Cray PJ
    Appl Environ Microbiol; 1983 Sep; 46(3):704-9. PubMed ID: 6357081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of somatic antigen of Vibrio cholerae in adhesion to intestinal mucosa.
    Chitnis DS; Sharma KD; Kamat RS
    J Med Microbiol; 1982 Feb; 15(1):53-61. PubMed ID: 7143426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of activation of adenylate cyclase by Vibrio cholerae enterotoxin. Relations to the mode of activation by hormones.
    Bennett V; Mong L; Cuatrecasas P
    J Membr Biol; 1975 Nov; 24(2):107-29. PubMed ID: 172636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
    Häse CC; Thai LS; Boesman-Finkelstein M; Mar VL; Burnette WN; Kaslow HR; Stevens LA; Moss J; Finkelstein RA
    Infect Immun; 1994 Aug; 62(8):3051-7. PubMed ID: 8039872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental studies on the pathogenicity of Vibrio mimicus strains isolated in Bangladesh.
    Sanyal SC; Huq MI; Neogy PK; Alam K; Kabir MI; Rahaman AS
    Aust J Exp Biol Med Sci; 1984 Aug; 62 ( Pt 4)():515-21. PubMed ID: 6517767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of extracellular toxin(s) produced by Vibrio vulnificus.
    Kreger A; Lockwood D
    Infect Immun; 1981 Aug; 33(2):583-90. PubMed ID: 7024134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The population composition of cultures of Vibrio cholerae strain 569 B Pakistan in relation to the manufacture of a cholera vaccine (choleragen-anatoxin+O-antigen)].
    Lobanov VV; Nechetskaia RM; Adamova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):73-6. PubMed ID: 2461623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man.
    Evans DJ; Evans DG; Gorbach SL
    Infect Immun; 1973 Nov; 8(5):725-30. PubMed ID: 4584048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine structure of Vibrio cholerae during toxin production.
    Kennedy JR; Richardson SH
    J Bacteriol; 1969 Dec; 100(3):1393-401. PubMed ID: 5361220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Permeability and enterotoxic factors of nonagglutinable vibrios Vibrio alcaligenes and Vibrio parahaemolyticus.
    Bhattacharya S; Bose AK; Ghosh AK
    Appl Microbiol; 1971 Dec; 22(6):1159-61. PubMed ID: 5137585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production and partial characterization of elastase of Vibrio cholerae Inaba.
    Tripathi KK; Kaur M; Gupta M; Gupta KG
    Zentralbl Bakteriol; 1989 Oct; 271(4):431-41. PubMed ID: 2818795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separation of type 2 toxins of Vibrio cholerae.
    Lewis AC; Freeman BA
    Science; 1969 Aug; 165(3895):808-9. PubMed ID: 5804723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on adhesion, haemagglutination and other biological properties of Vibrio cholerae O139.
    Sasmal D; Guhathakurta B; Ghosh AN; Pal CR; Datta A
    FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):199-205. PubMed ID: 7773236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralisation of the new cholera toxin by antiserum against crude enterotoxin of cholera toxin gene-positive Vibrio cholerae 01 in rabbit ileal loop model.
    Saha S; Sanyal SC
    Indian J Med Res; 1989 May; 89():117-20. PubMed ID: 2777342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental Toxigenicity of NAG Vibrios.
    Draskovicová M; Karolcek J; Winkler
    Zentralbl Bakteriol Orig A; 1977 Feb; 237(1):65-71. PubMed ID: 842178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of the vascular permeability factor of Vibrio cholerae.
    Craig JP
    J Bacteriol; 1966 Sep; 92(3):793-5. PubMed ID: 5922548
    [No Abstract]   [Full Text] [Related]  

  • 38. Repression of the alkaline phosphatase of Vibrio cholerae.
    Roy NK; Ghosh RK; Das J
    J Gen Microbiol; 1982 Feb; 128(2):349-53. PubMed ID: 7077294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choleragen-mediated release of trapped glucose from liposomes containing ganglioside GM1.
    Moss J; Fishman PH; Richards RL; Alving CR; Vaughan M; Brady RO
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3480-3. PubMed ID: 1068459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Groups of the species Vibrio cholerae having different epidemic importance].
    Semiotrochev VL
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):54-8. PubMed ID: 2385990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.